A
$ Value
$14K
Shares
6,740
Price
$2
Filed
Oct 3
Insider
Name
GROGAN DONNA ROY
Title
—
CIK
0001788455
Roles
Director
Transaction Details
Transaction Date
2025-10-01
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
58,629
Footnotes
These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. | The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2025.
Filing Info
GROGAN DONNA ROY's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | CCCC | A | $14K |
| 2026-01-02 | CCCC | A | $15K |
| 2025-10-01 | CCCC | A | $14K |
| 2025-07-01 | CCCC | A | $15K |
| 2025-06-18 | CCCC | A | $0 |
Other Insiders at CCCC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
REYNO LEONARD
Chief Medical Officer
|
— | — | 2026-02-14 |
|
Hirsch Andrew
President & CEO
|
— | — | 2026-02-15 |
| GROGAN DONNA ROY | — | — | 2026-04-01 |
|
Schick Kelly
Chief People Officer
|
— | — | 2026-02-14 |
| Anderson Kenneth Carl | — | — | 2026-04-01 |
|
Boyle Scott N
Chief Business Officer
|
— | — | 2026-02-14 |
|
Adams Kendra
Chief Financial Officer
|
— | — | 2026-02-14 |
|
Mossler Mark
Chief Accounting Officer
|
— | — | 2026-02-14 |
|
Mahaney Paige
Chief Scientific Officer
|
— | — | 2026-02-14 |